Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

BACKGROUND Women who have had a spontaneous preterm delivery are at greatly increased risk for preterm delivery in subsequent pregnancies. The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery. METHODS We conducted a double-blind, placebo-controlled trial involving pregnant women with a documented history of spontaneous preterm delivery. Women were enrolled at 19 clinical centers at 16 to 20 weeks of gestation and randomly assigned by a central data center, in a 2:1 ratio, to receive either weekly injections of 250 mg of 17P or weekly injections of an inert oil placebo; injections were continued until delivery or to 36 weeks of gestation. The primary outcome was preterm delivery before 37 weeks of gestation. Analysis was performed according to the intention-to-treat principle. RESULTS Base-line characteristics of the 310 women in the progesterone group and the 153 women in the placebo group were similar. Treatment with 17P significantly reduced the risk of delivery at less than 37 weeks of gestation (incidence, 36.3 percent in the progesterone group vs. 54.9 percent in the placebo group; relative risk, 0.66 [95 percent confidence interval, 0.54 to 0.81]), delivery at less than 35 weeks of gestation (incidence, 20.6 percent vs. 30.7 percent; relative risk, 0.67 [95 percent confidence interval, 0.48 to 0.93]), and delivery at less than 32 weeks of gestation (11.4 percent vs. 19.6 percent; relative risk, 0.58 [95 percent confidence interval, 0.37 to 0.91]). Infants of women treated with 17P had significantly lower rates of necrotizing enterocolitis, intraventricular hemorrhage, and need for supplemental oxygen. CONCLUSIONS Weekly injections of 17P resulted in a substantial reduction in the rate of recurrent preterm delivery among women who were at particularly high risk for preterm delivery and reduced the likelihood of several complications in their infants.

[1]  Shiv k. Sharma,et al.  Intensity of Labor Pain and Cesarean Delivery , 1999, Anesthesia and analgesia.

[2]  M. Lancet,et al.  Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. , 1985, American journal of obstetrics and gynecology.

[3]  An Association Between Severe Labor Pain and Cesarean Delivery , 2000, Anesthesia and analgesia.

[4]  G. Thurnau,et al.  The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1998, American journal of obstetrics and gynecology.

[5]  F. Fuchs,et al.  Treatment of threatened premature labor with large doses of progesterone. , 1960, American journal of obstetrics and gynecology.

[6]  S F Bottoms,et al.  The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. , 1998, American journal of public health.

[7]  G. Swyer,et al.  Progesterone Implantation in Habitual Abortion , 1953, British medical journal.

[8]  E. Daniel,et al.  Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins. , 1980, The American journal of physiology.

[9]  R. Creasy,et al.  Preterm birth prevention: where are we? , 1993, American journal of obstetrics and gynecology.

[10]  L. J. Wei,et al.  Properties of the urn randomization in clinical trials. , 1988, Controlled clinical trials.

[11]  M. Seron-Ferre,et al.  SOME NEW THOUGHTS ON THE FETOPLACENTAL UNIT AND PARTURITION IN PRIMATES , 1981 .

[12]  N. Paneth,et al.  The problem of low birth weight. , 1995, The Future of children.

[13]  R. Tuimala,et al.  Inefficacy of 17α‐Hydroxyprogesterone Caproate in the Prevention of Prematurity in Twin Pregnancy , 1980, Obstetrics and gynecology.

[14]  M. Zugaib,et al.  Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. , 2003, American journal of obstetrics and gynecology.

[15]  F. Søndergaard,et al.  Traitement par la progestérone des menaces d'accouchement prématuré avec taux bas de progestérone plasmatique , 1985 .

[16]  C. Hobel,et al.  The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women , 1994 .

[17]  T. Einarson,et al.  FETAL GENITAL EFFECTS OF FIRST‐TRIMESTER SEX HORMONE EXPOSURE: A META‐ANALYSIS , 1995, Obstetrics and gynecology.

[18]  Elizabeth A Thom,et al.  Frequency of uterine contractions and the risk of spontaneous preterm delivery. , 2002, The New England journal of medicine.

[19]  R. Frydman,et al.  Labor induction in women at term with mifepristone (RU 486): A double‐blind, randomized, placebo‐controlled study , 1992, Obstetrics and gynecology.

[20]  K. K. Lan,et al.  Discrete sequential boundaries for clinical trials , 1983 .

[21]  J. Challis.  Sharp Increase in Free Circulating Oestrogens Immediately Before Parturition in Sheep , 1971, Nature.

[22]  J. Schardein.  Congenital abnormalities and hormones during pregnancy: a clinical review. , 1980, Teratology.

[23]  L. Gilstrap,et al.  The effect of 17α-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population , 1983 .

[24]  J. Goldzieher.  DOUBLE-BLIND TRIAL OF A PROGESTIN IN HABITUAL ABORTION. , 1964, JAMA.

[25]  S. Emerson,et al.  Dose-response relationship of intrathecal morphine for postcesarean analgesia. , 1999, Anesthesiology.

[26]  M. Keirse.  Progestogen administration in pregnancy may prevent preterm delivery , 1990, British journal of obstetrics and gynaecology.

[27]  M. Lancet,et al.  Prevention of premature labor by 17α-hydroxyprogesterone caproate , 1985 .

[28]  T. Chalmers,et al.  A meta‐analysis of randomized control trials of progestational agents in pregnancy , 1989, British journal of obstetrics and gynaecology.

[29]  D. Mattison,et al.  Preterm delivery: a public health perspective. , 2001, Paediatric and perinatal epidemiology.

[30]  J. Challis,et al.  Local modulation of progesterone production in human fetal membranes. , 1982, The Journal of clinical endocrinology and metabolism.

[31]  Chin-peng Lee,et al.  The Preterm Prediction Study: Recurrence risk of spontaneous preterm birth , 1998 .